Source: Journal of Allergy and Clinical Immunology. Unidade: FMRP
Subjects: SÍNDROMES DE DEFICIÊNCIA IMUNOLÓGICA, INIBIDORES DE ENZIMAS, ESTUDOS PROSPECTIVOS, ESTUDOS RANDOMIZADOS, RESULTADO DE TRATAMENTO
ABNT
FISCHER, Marco et al. JAK inhibitor treatment for inborn errors of JAK/STAT signalin: an ESID/EBMT-IEWP retrospective study. Journal of Allergy and Clinical Immunology, v. 153, n. 1, p. 275-286.e18, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.jaci.2023.10.018. Acesso em: 27 ago. 2024.APA
Fischer, M., Olbrich, P., Hadjadj, J., Aumann, V., Bakhtiar, S., Barlogis, V., et al. (2024). JAK inhibitor treatment for inborn errors of JAK/STAT signalin: an ESID/EBMT-IEWP retrospective study. Journal of Allergy and Clinical Immunology, 153( 1), 275-286.e18. doi:10.1016/j.jaci.2023.10.018NLM
Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, Bloomfield M, Booth C, Buddingh EP, Cagdas D, Castelle M, Roxo Júnior P, Júnior PR. JAK inhibitor treatment for inborn errors of JAK/STAT signalin: an ESID/EBMT-IEWP retrospective study [Internet]. Journal of Allergy and Clinical Immunology. 2024 ; 153( 1): 275-286.e18.[citado 2024 ago. 27 ] Available from: https://doi.org/10.1016/j.jaci.2023.10.018Vancouver
Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, Bloomfield M, Booth C, Buddingh EP, Cagdas D, Castelle M, Roxo Júnior P, Júnior PR. JAK inhibitor treatment for inborn errors of JAK/STAT signalin: an ESID/EBMT-IEWP retrospective study [Internet]. Journal of Allergy and Clinical Immunology. 2024 ; 153( 1): 275-286.e18.[citado 2024 ago. 27 ] Available from: https://doi.org/10.1016/j.jaci.2023.10.018